EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NAD+ precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL

Lizhi Shi, Xuezhu Huang, Xiao Han, Chenchen Ning, Xinyi Zhao, Haohao Li, Zhe Yu, Qiuju Han

Pharmaceutical Science Advances · 2026-12 · 4 · 100111

DOI: 10.1016/j.pscia.2026.100111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Science Advances, 2026-12. Verfasst von Lizhi Shi und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Shando…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CD36DLBCLLipid metabolismNAD+NK cell

Autor:innen und Institutionen

  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong, China.
  • Department of Hematology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.
  • Department of Hematology, Shandong Provincial Third Hospital, Jinan, Shandong, China.

Förderung

  • National Natural Science Foundation of China
  • Shandong Province Natural Science Foundation

Zitieren

APA

Shi, L., Huang, X., Han, X., Ning, C., Zhao, X., Li, H., Yu, Z., & Han, Q. (2026). NAD+ precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL. Pharmaceutical Science Advances, 4, 100111. https://doi.org/10.1016/j.pscia.2026.100111

Vancouver

Shi L, Huang X, Han X, Ning C, Zhao X, Li H, et al. NAD+ precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL. Pharmaceutical Science Advances. 2026;4:100111. doi:10.1016/j.pscia.2026.100111

BibTeX
@article{Shi2026,
  author = {Shi, Lizhi and Huang, Xuezhu and Han, Xiao and Ning, Chenchen and Zhao, Xinyi and Li, Haohao and Yu, Zhe and Han, Qiuju},
  title = {NAD+ precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCL},
  journal = {Pharmaceutical Science Advances},
  year = {2026},
  volume = {4},
  pages = {100111},
  doi = {10.1016/j.pscia.2026.100111}
}
Kostenlos starten →